Health experts say the benefits outweigh the risks and recommend the FDA authorise the vaccine.
A US government panel has voted to recommend the Pfizer/BioNTech vaccine should to be given to children aged five to 11.
The Food and Drug Administration experts backed the move on Tuesday, paving the way for emergency authorisation within a matter of weeks. In September, the company said its trial data showed the Covid jab was safe for children in that age group.This latest decision affects some 28 million US children.
The decision now awaits further approval from the FDA and the Centers for Disease Control and Prevention . They are expected to do that on 2 November, meaning vaccinations could begin the very next day. The FDA's expert panel determined that the benefits of having the jab outweigh any other health risks.the jabs produced a "robust" antibody immune responseChildren aged five to 11 are given a jab with a third of the dosage given to adults.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
U.S. FDA advisers weigh Pfizer/BioNTech COVID-19 vaccine in childrenAn expert panel will weigh authorization of Pfizer Inc and BioNTech's COVID-19 vaccine for U.S. children aged 5 to 11 on Tuesday as it prepares to vote on a recommendation for the federal Food and Drug Administration.
Read more »
COVID-19 live updates: FDA panel hours away from vote on Pfizer vaccine for kidsAn independent FDA advisory panel will debate and vote on whether to authorize the Pfizer vaccine for children ages 5 to 11. The nonbinding vote is expected between 4:30 p.m. and 5 p.m. ET today.
Read more »
Pfizer CEO says company will produce 4 billion COVID-19 doses in 2022Pfizer CEO Albert Bourla says the company is increasing its output to meet global demand.
Read more »
FDA Advisers Back Pfizer’s COVID-19 Vaccine For Young Kids Ages 5-11U.S. health advisers have endorsed kid-size doses of Pfizer's COVID-19 vaccine for younger children.
Read more »
FDA panel backs Pfizer’s low-dose COVID-19 vaccine for kidsBREAKING: FDA advisers endorse Pfizer’s COVID-19 vaccine for children ages 5 to 11. The FDA isn’t bound by the recommendation and is expected to make a decision within days. The kid-sized dose is a third of the Pfizer shot that adults received.
Read more »